Target Discovery for RNA Therapeutics workshop at Oligonucleotide Therapeutics Conference 2021

SMi reports: Running alongside the main conference will be an interactive pre-conference workshop on 21st September 2021 on 'Target Discovery for RNA Therapeutics'
By: SMi Group
 
LONDON - July 28, 2021 - PRLog -- Workshop Leader: Martin Akerman, Chief Technology Officer, Envisagenics

Featuring Workshop Guest Speakers from: Envisagenics, Eli Lilly, InteRNA Technologies, HAYA Therapeutics, Stoke Therapeutics and ARNAY Sciences

The field of RNA therapeutics has been rapidly gaining momentum. In parallel, methodologies for early discovery have been taking a new form. Combining the now-accessible resources such as big data, multi-omics, and high-performance computing, this new ecosystem of R&D approaches has been surfacing.

This workshop will explore:
  • Different perspectives on building a multi-disciplinary team
  • Data-driven innovation for a biotechnology company
  • Novel discovery platforms with horizontal applications
  • Strategic insights in the field of RNA therapeutics

Register online: www.oligonucleotide.co.uk/prlog6

RNA Therapeutics in Oncology: Advances and Challenges
  • With the support of Envisagenics' proprietary machine learning modules, high performance computing, and splicing analytics, Envisagenics identified a novel target and designed and validated RNA therapeutic compound in 8 months
  • Focusing on antisense oligonucleotides as a viable therapeutic modality in oncology and other applicable therapeutic areas
  • Overcoming limitations to computational outputs and executing necessary validation experiments for in-silico identified targets

Gayatri Arun, Vice President of Biology, Envisagenics

Download a copy of your brochure to find out who will be speaking at the upcoming conference in September www.oligonucleotide.co.uk/prlog6

Proudly Sponsored by ChemGenes | Genscript | Tosoh Bioscience

SMi Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages. For more details and all delegate enquiries please contact Alia Malick on: +44 (0)20 7827 6168.

For media queries please contact Jinna Sidhu at hsidhu@smi-online.co.uk or call +44 (0)20 7827 6088.

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Contact
Jinna Sidhu
***@smi-online.co.uk
End
Email:***@smi-online.co.uk
Posted By:***@smi-online.co.uk Email Verified
Tags:#SMiOligonucleotides
Industry:Health
Location:London City - London, Greater - England
Subject:Features
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share